Next-Generation Pharmacotherapies in Obesity: Transforming Care with Precision and Multisystem Benefits
Emerging obesity pharmacotherapies targeting entero-pancreatic hormones deliver substantial weight loss and improve multiple obesity-related complications, heralding a treat-to-target paradigm in obesity management with personalized, complication-centric care.